Abbott Laboratories Cartridge Gets FDA Clearance to be Used with Whole Blood
By Denny Jacob
Abbott Laboratories' i-STAT TBI cartridge received clearance from the Food and Drug Administration to be used with whole blood, offering an additional tool for people with suspected concussions.
The healthcare-products manufacturer said the cartridge's ability to use whole blood will provide lab-quality results in 15 minutes.
Abbott said the clearance will enable testing in new healthcare settings beyond hospital emergency departments including urgent care clinics with a certificate to perform moderate complexity tests.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
April 01, 2024 09:34 ET (13:34 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
These Stocks Are (Still) Powering the Bull Market
-
5 Undervalued Energy Stocks to Play the AI Data Center Demand Boom
-
After Earnings, Is Lowe’s Stock a Buy, Sell, or Fairly Valued?
-
5 Stocks With the Largest Fair Value Estimate Cuts After Q1 Earnings
-
10 Stocks With the Largest Fair Value Estimate Increases After Q1 Earnings
-
Markets Brief: Inflation Back in the Spotlight
-
AI Is Booming, but Consumer Spending Is Slowing. Which Will Prevail in the Stock Market?
-
What’s Happening In the Markets This Week
-
3 Dividend Stocks for June 2024
-
After Earnings, Is Alibaba Stock a Buy, Sell, or Fairly Valued?
-
MongoDB Earnings: Slashing Valuation as Execution and Macro to Blame for Lower Guidance
-
Marvell Earnings: We Raise Our Medium-Term AI Forecast and Bring Our Valuation Up to $75
-
Zscaler Earnings: Impressive Traction in Emerging Products Drives Sales Growth for the Quarter
-
Dell Earnings: Raising Valuation on Strong AI, but the Stock Remains Severely Overvalued
-
After Earnings, Is Nvidia Stock a Buy, Sell, or Fairly Valued?
-
The 10 Best Companies to Invest in Now